Microbes are essential to all life on earth and, in fact, the most dominant form of life on Earth. The study of microbes has historically advanced society in countless ways such as the creation of the first smallpox vaccine, identifying the causes of cholera, tuberculosis, and anthrax, and the discovery of penicillin. Today, microbes in controlled settings can improve healthcare, food production, and agricultural output. Seed Health is a microbial science company that is focused on developing next-generation probiotic and live biotherapeutics for consumer use. Unlike traditional biotech companies that work to solve a single, isolated problem, Seed Health is structured as a platform that is able to synthesize its findings into a growing number of consumer use cases, following a rigorous process that handles development, validation, research, deployment and scaling up. LA TechWatch caught up with Cofounder and Co-CEO Ara Katz to learn more about the importance of microbiomes, the company’s strategic plans, and latest round of funding from investors that include The Craftory, ARTIS Ventures, GISEV, Founders Fund, and 8VC.